Last updated: April 26, 2026
Who supplies Tazorac (tazarotene) to the market?
What is “Tazorac” and what are the known manufacturing/supply holders?
Tazorac is the brand name for tazarotene, a topical retinoid. In most markets where Tazorac is marketed, the drug product is supplied under the brand through a commercial rights holder tied to the FDA label and distribution channels.
Key supply identifiers tied to the US regulatory record:
| Market |
Product |
Active |
Regulated holder shown on label/distribution context |
Supplier/manufacturer on US label context |
| United States |
Tazorac (tazarotene) topical gel/cream |
Tazarotene |
Listed as brand holder on labeling |
Manufacturer/distributor names appear on the package insert and/or FDA label text |
Because “Tazorac” is a brand, the practical “supplier” question in procurement terms splits into two layers:
1) Regulatory/brand supply chain (who holds the commercial label and drives distribution).
2) Product manufacturing (who actually makes the finished dosage form and/or who supplies the finished product to the market).
No defensible, complete supplier list can be produced from the single term “Tazorac” alone without pulling the specific labeling/manufacturer/distributor entries for the exact formulation(s) and strength(s) being purchased.
Which exact Tazorac SKUs matter for supplier identification?
Supplier names differ by SKU (strength/formulation) because the finished dosage form can be produced by different contractors and shipped through different distribution arrangements.
Tazorac is marketed in multiple strengths and dosage forms, commonly including:
- Tazorac 0.05%
- Tazorac 0.1%
The “supplier” for a procurement bid should be SKU-specific because the label manufacturing/distribution block is not guaranteed to be identical across:
- gel vs cream
- strength (0.05% vs 0.1%)
- NDC/pack size
What supplier categories exist for Tazorac purchasing?
For sourcing work, the supplier universe breaks into four practical buckets:
-
Finished drug product manufacturer(s)
The company that manufactures the packaged dosage form listed on the US label.
-
Marketing/distribution entity
The firm that sells and distributes under the brand name in the relevant country.
-
Active pharmaceutical ingredient (API) supplier(s)
Tazarotene API sourcing is typically by contract and can be obscured in public-facing label data.
-
Contract manufacturing organizations (CMOs) and packaging contractors
Often appear indirectly through label manufacturing and NDC manufacturing details.
What can be stated with high confidence from available public structure?
The public-facing “supplier” information for Tazorac procurement is anchored to:
- FDA labeling (package insert / prescribing information) manufacturer and distributor blocks for the specific NDC/SKU, and
- NDC-related labeling text (which usually lists either the manufacturer or distributor).
However, without the precise NDC, strength, and dosage form, a complete and accurate supplier roster cannot be enumerated.
What sources normally identify the correct supplier names?
When you need a defensible supplier list for Tazorac, the actionable record set is:
- FDA Prescribing Information / Medication Guide (shows label holder and manufacturing/distribution line)
- FDA Structured Product Labeling (SPL) (often contains the explicit manufacturer and distributor fields)
- NDC directory entries tied to the exact NDC for each strength and dosage form
These are the records procurement teams use to avoid “brand holder vs manufacturer” confusion.
Key Takeaways
- “Tazorac” is a brand for tazarotene, and supplier names vary by SKU (gel vs cream) and strength (0.05% vs 0.1%).
- The most defensible “supplier” identification comes from FDA label/SPL fields tied to the exact NDC for the formulation being sourced.
- A complete, accurate supplier list cannot be provided from the generic product name alone without mapping the specific Tazorac NDC(s) to the label’s manufacturer/distributor entries.
FAQs
-
Is the brand holder the same as the manufacturer for Tazorac?
Not necessarily. Brand distribution and finished drug product manufacturing are often different entities.
-
Do supplier names change between Tazorac gel and Tazorac cream?
Yes. Manufacturing and packaging contractors can differ by dosage form, even within the same brand.
-
Why do procurement teams require the exact NDC?
NDC is the link to the specific label and manufacturing/distribution text for that SKU.
-
Are tazarotene API suppliers publicly listed on the Tazorac label?
Commonly not, or not in a complete way suitable for contracting. Labels usually focus on the finished product manufacturer and distributor.
-
What is the fastest way to verify the supplier for a specific Tazorac item?
Use the FDA SPL/label text for the exact NDC corresponding to the strength and dosage form.
References
[1] U.S. Food and Drug Administration. “Structured Product Labeling (SPL) for Tazorac (tazarotene).” FDA.
[2] U.S. Food and Drug Administration. “NDC Directory.” FDA.
[3] U.S. Food and Drug Administration. “Prescribing Information / Label for Tazorac (tazarotene).” FDA.
